ROLE OF URINARY-EXCRETION OF MAGNESIUM IN PATIENTS WITH UROLITHIASIS WITH SPECIAL RESPECT TO RECURRENCE RATE OF STONE FORMATION

被引：0
|
作者：
ZECHNER, O
LATAL, D
机构：
来源：
UROLOGE-AUSGABE A | 1978年 / 17卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：258 / 260
页数：3
相关论文
共 50 条
  • [21] UROLITHIASIS IN SOUTHERN RAJASTHAN (WESTERN REGION OF INDIA) .3. URINARY-EXCRETION OF CALCIUM AND OXALATE IN NORMAL POPULATION AND STONE FORMERS
    SINGH, PP
    PENDSE, AK
    UROLOGICAL RESEARCH, 1984, 12 (01): : 60 - 60
  • [22] SIGNIFICANCE OF URINARY-EXCRETION OF STONE COMPONENTS IN LONG-TERM FOLLOW-UP OF CALCIUM STONE PATIENTS
    MASUSHITA, K
    TANIKAWA, K
    UROLOGICAL RESEARCH, 1988, 16 (03): : 245 - 245
  • [23] EFFECT OF CARBOHYDRATE INTAKE ON URINARY-EXCRETION OF MAGNESIUM, CALCIUM AND SODIUM IN FASTING OBESE PATIENTS
    FLEMING, LW
    STEWART, WK
    NEPHRON, 1976, 16 (01): : 64 - 73
  • [24] THE EFFECT OF PIRETANIDE UPON THE URINARY-EXCRETION OF CALCIUM AND MAGNESIUM IN NORMAL SUBJECTS AND HYPOPARATHYROID PATIENTS
    MAUTALEN, C
    CASCO, C
    MASSIRONI, C
    GHIRINGHELLI, G
    UROLOGICAL RESEARCH, 1984, 12 (01): : 65 - 65
  • [25] The Role of Blood Pressure Towards Radiopaque Stone Formation in Urolithiasis Patients
    Bramono, Ikhlas Arief
    Rasyid, Nur
    Atmoko, Widi
    Birowo, Ponco
    ADVANCED SCIENCE LETTERS, 2018, 24 (09) : 6972 - 6975
  • [26] URINARY-EXCRETION OF OXALATE BY PATIENTS WITH RENAL HYPERCALCIURIC STONE DISEASE - EFFECT OF CHRONIC TREATMENT WITH HYDROCHLOROTHIAZIDE
    URIVETZKY, M
    BRAVERMAN, S
    MOTOLA, JA
    SMITH, AD
    UROLOGY, 1991, 37 (04) : 327 - 330
  • [27] URINARY-EXCRETION OF INORGANIC PYROPHOSPHATE BY NORMAL SUBJECTS AND PATIENTS WITH RENAL CALCULI IN NORTH-WESTERN INDIA AND THE EFFECT OF DICLOFENAC SODIUM UPON URINARY-EXCRETION OF PYROPHOSPHATE IN STONE FORMERS
    SHARMA, S
    VAIDYANATHAN, S
    THIND, SK
    NATH, R
    UROLOGIA INTERNATIONALIS, 1992, 48 (04) : 404 - 408
  • [28] URINARY-EXCRETION OF 6-OH-CHLORZOXAZONE (CXZ-OH) IS FORMATION RATE LIMITED
    DREISBACH, AW
    FERENCZ, N
    HOPKINS, NE
    FUENTES, MG
    REGE, AB
    GEORGE, WJ
    LERTORA, JJL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 217 - 217
  • [29] THERAPY FOR UROLITHIASIS BY HYDROXAMIC ACIDS .2. UREASE INHIBITORY POTENCY AND URINARY-EXCRETION RATE OF HIPPUROHYDROXAMIC ACID-DERIVATIVES
    KOBASHI, K
    MUNAKATA, K
    TAKEBE, S
    HASE, J
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1980, 3 (09): : 444 - 450
  • [30] THERAPY FOR UROLITHIASIS BY HYDROXAMIC ACIDS .3. UREASE INHIBITORY POTENCY AND URINARY-EXCRETION RATE OF N-ACYLGLYCINOHYDROXAMIC ACIDS
    MUNAKATA, K
    KOBASHI, K
    TAKEBE, S
    HASE, J
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1980, 3 (09): : 451 - 456
12345